Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. - Wikidata - awgldk - TriplyDB

Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis.

Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis.

http://www.wikidata.org/entity/Q36761383

about

IL-35 is a novel responsive anti-inflammatory cytokine--a new system of categorizing anti-inflammatory cytokines Interleukin-35: Expanding Its Job Profile The modulation of endoplasmic reticulum stress by chemical chaperone upregulates immune negative cytokine IL-35 in apolipoprotein E-deficient mice Interleukin-35: a Potential Therapeutic Agent for Autoimmune Diseases.Interleukin 35 may contribute to the loss of immunological self-tolerance in patients with primary immune thrombocytopenia.Increased plasma concentrations of interleukin 35 in patients with coronary artery disease.The possible role of the novel cytokines il-35 and il-37 in inflammatory bowel disease.IL-12 family cytokines: immunological playmakers Cytokine-modulating strategies and newer cytokine targets for arthritis therapy.Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases.Contribution of IL-12/IL-35 common subunit p35 to maintaining the testicular immune privilege.High IL-35 pleural expression in patients with tuberculous pleural effusion.Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis.CD4+VEGFR1(HIGH) T cell as a novel Treg subset regulates inflammatory bowel disease in lymphopenic mice Assessing the role of IL-35 in colorectal cancer progression and prognosis.Effects of an intravitreal injection of interleukin-35-expressing plasmid on pro-inflammatory and anti-inflammatory cytokines.IL-35 improves Treg-mediated immune suppression in atherosclerotic mice Interleukin-35-Producing CD8α+ Dendritic Cells Acquire a Tolerogenic State and Regulate T Cell Function.Regulatory T-cell vaccination independent of auto-antigen.Interleukin 35 Polymorphisms Are Associated with Decreased Risk of Premature Coronary Artery Disease, Metabolic Parameters, and IL-35 Levels: The Genetics of Atherosclerotic Disease (GEA) Study.What's the next best cytokine target in IBD?The price of immunity.Changes of the cytokine profile in inflammatory bowel diseases.Interleukin 35: a key mediator of suppression and the propagation of infectious tolerance.Targeting interleukins for the treatment of inflammatory bowel disease-what lies beyond anti-TNF therapy?IL-35: a potential therapeutic target for controlling hepatitis B virus infection.IL-35 and Autoimmunity: a Comprehensive Perspective.Endoplasmic reticulum stress in intestinal epithelial cell function and inflammatory bowel disease Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.Pathogenic T cell subsets in allergic and chronic inflammatory bowel disorders.IL-35 Suppresses Lipopolysaccharide-Induced Airway Eosinophilia in EBI3-Deficient Mice.Post-therapeutic recovery of serum interleukin-35 level might predict positive response to immunosuppressive therapy in pediatric aplastic anemia.Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature.Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.Recent Advances: The Imbalance of Cytokines in the Pathogenesis of Inflammatory Bowel Disease.Interluekin-35 in Asthma and Its Potential as an Effective Therapeutic Agent.Plasma Level of Interleukin-35 as an Independent Prognostic Indicator in Hepatocellular Carcinoma.Gene Expression and Antiviral Activity of Interleukin-35 in Response to Influenza A Virus Infection.Level of Interleukin-35 in Gingival Crevicular Fluid, Saliva, and Plasma in Periodontal Disease and Health.Interleukin-35 on B cell and T cell induction and regulation.

P2860

Q21090933-70C92C43-97B0-4C26-B57F-CF48432A4208 Q26829619-DD2549D8-0297-4609-882D-25CF0546D4CF Q28539349-11C50CE4-8F2F-4656-9135-7A3FD681B58E Q30244926-50830D41-F621-4C96-B2BA-83BA20925511 Q33420102-DE8A3144-FD03-4E83-969E-50AF80724276 Q33904487-D34099F3-6563-4B3E-8123-41E097628E53 Q34119277-64C891AC-2E82-4670-B026-39693F096185 Q34153998-0D3926AE-84F1-4FD8-9205-92CC82671C94 Q34456715-A44AEEEA-FEE8-4052-B0BB-5B84D29A6336 Q34534000-E8119067-EA95-4AC8-B6B6-5BF595168937 Q35156199-30D3981F-1A8A-45ED-876F-F016E8C604CA Q35605534-A3F4C229-58BA-452B-9C03-26CC83703077 Q35882730-C1442AB5-094A-4FB2-BF49-89780AE40F5B Q36085110-7C105FA9-8951-45DC-BB39-B173559D3671 Q37137999-0FE56FAC-878A-49EE-AB97-DFD346989EBB Q37187572-810EE4F2-F0F4-43AE-8561-0FD05DDF1C61 Q37289372-BDF1990E-AFAF-486C-955C-4FD60DBAEB80 Q37629868-983099A4-504F-4B6E-98C3-27F1205017FE Q37679455-C409D7C8-1967-4E36-AD10-D9DB982B8467 Q37685707-BD5B4B45-D75C-460D-83F5-360B572697DD Q38003092-43417493-0FD3-4CB6-B6EA-D4C79484483F Q38044667-483CA259-CD59-477C-BBAC-F7C9FC4ED275 Q38058782-AE15487F-2DF5-4B5E-83AF-55E7B7FFF87D Q38154886-EEDDC464-C1FC-4564-91D5-9ADCF964DABA Q38172801-FAAD24A3-4FB9-4381-9AC6-348E823548E2 Q38283391-C87413E0-0E45-4616-84F9-C3D786ABBB86 Q38331780-5C503ED6-1851-4F67-A20D-E99D3126F61F Q38371666-0BEAA552-CC05-4F54-9A48-DDAB96D2779A Q38537820-4E1ED77F-2EFB-4D36-81B8-2C21A28417CD Q38665573-DFE6E931-12EA-49EF-85E0-E9610AE07851 Q38729193-CFC05622-8817-4A53-AB46-480D6F58ECDE Q38756198-556D1831-073A-4C8B-A468-ADD6AA1DB961 Q38848936-CCC4FB42-000D-476B-8402-C8DD7D576424 Q39015080-A3A4FAAD-0A83-4F99-BE4D-425403A92766 Q39249504-BF9B0AA2-1356-432C-9E74-DB2EBB9F0BAA Q39335458-F5948FF2-40DF-4A2D-8AB6-2DE8D7164DF5 Q40555375-9354C693-7733-436D-AFDF-89C9C5D1C9F0 Q40699208-09A7952C-13AD-4228-8E68-52C52EAB9CE7 Q41197467-AD03BCB1-25D5-4615-A8CF-7D10449046AE Q41292130-B062A5B9-77BD-4ECD-BEF9-B891D6B39854

P2860

Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis.

http://www.wikidata.org/entity/Q36761383

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Interleukin-35 mediates mucosa ...... inst T-cell-dependent colitis.

@ast

Interleukin-35 mediates mucosa ...... inst T-cell-dependent colitis.

@en

type

label

Interleukin-35 mediates mucosa ...... inst T-cell-dependent colitis.

@ast

Interleukin-35 mediates mucosa ...... inst T-cell-dependent colitis.

@en

prefLabel

Interleukin-35 mediates mucosa ...... inst T-cell-dependent colitis.

@ast

Interleukin-35 mediates mucosa ...... inst T-cell-dependent colitis.

@en

P1433

Q36761383-46EB6347-A126-4117-955E-8BBAA44FD4A4

P1476

Q36761383-83061C58-8ED2-4F96-8B74-3661E6A27558

P2093

Q36761383-5054F162-70F1-4EEF-A4A0-ECA553FA3CAD

Q36761383-60DE285C-3334-41BE-ABD9-D05DC63F7712

Q36761383-7B605A9E-24F2-4DC2-9795-E52B58B4AE20

Q36761383-84972EB1-46A2-4379-982B-2F9F6C896F1B

P2860

Q36761383-14860ADE-E635-4D80-AC4E-BB4787F121D1

Q36761383-1E103798-4864-4E55-8F4C-7B151320735E

Q36761383-2B312020-D2F6-4B7F-9059-F3EA5EB91917

Q36761383-2E65CBC5-1AA5-4B4D-B695-E4A68FE1E88B

Q36761383-3E32CE8B-1250-476F-917E-C3F0523FF40C

Q36761383-4495A0E6-EBAF-40BE-8657-31898D8C9291

Q36761383-4F2F184D-2113-448E-9C48-8683628DD5E3

Q36761383-529FAED1-9EE6-4975-B06A-4AA4100D4182

Q36761383-673A9708-9FE0-4148-9B08-2174AF2C9814

Q36761383-72F6271B-16B2-45FB-B624-8C9BE10321E3

P304

Q36761383-5811B34C-B0CA-4D0C-A2A3-99F651B8BA75

P31

Q36761383-7CE1750C-69CF-44BB-B3D2-39097176CE08

P356

Q36761383-7A7F90BC-49B1-457F-8AF1-DB8564A32C0A

P407

Q36761383-B6ED36D4-28AF-4F6B-8133-9E91CD02F14F

P433

Q36761383-3277DFD3-1039-405C-83D7-B0398E44433B

P478

Q36761383-04D5AB9B-6019-46F5-85A7-8A307C64FE9E

P50

Q36761383-57E5FED3-55E5-421B-987F-7546837D9A45

P577

Q36761383-726D8041-5532-4D50-8418-D1F46440703E

P5875

Q36761383-39DDDD64-BFA9-4EC7-B0ED-A8DC48C0AA1C

P698

Q36761383-040B9B08-8A70-4D55-A08F-B93DDAAC0A8B

P932

Q36761383-FCA4DA58-B6CA-4935-BC26-E65F139F6B20

P356

J.GASTRO.2011.07.040

P1433

Gastroenterology

P1476

Interleukin-35 mediates mucosa ...... ainst T-cell-dependent colitis

@en

P2093

Markus F Neurath

http://www.w3.org/2001/XMLSchema#string

Richard S Blumberg

http://www.w3.org/2001/XMLSchema#string

Tamuna Mchedlidze

http://www.w3.org/2001/XMLSchema#string

Ulrike Billmeier

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of IL-27 in human Th1-associated granulomatous diseases

High-throughput engineering of the mouse genome coupled with high-resolution expression analysis

IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells

IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Anti-interleukin-12 antibody for active Crohn's disease

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

Relative expression software tool (REST©) for group-wise comparison and statistical analysis of relative expression results in real-time PCR

Unravelling the pathogenesis of inflammatory bowel disease

IL-27 regulates homeostasis of the intestinal CD4+ effector T cell pool and limits intestinal inflammation in a murine model of colitis.

P304

1875-1886

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2011.07.040

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

141

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51550889

http://www.w3.org/2001/XMLSchema#string

P698

21820391

http://www.w3.org/2001/XMLSchema#string

P932

3624892

http://www.w3.org/2001/XMLSchema#string